CompaniesAviron

Aviron

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

15,030

By Phase

NA: 1PHASE3: 1

By Status

UNKNOWN: 1COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

Today

Hover over trial bars to see details

Recent Trials

NCT04527133Lead Sponsor

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

30 participants

Started: Jun 11, 2020 · Completed: Aug 31, 2020

NCT00001127Collaborator

Study of a Flu Vaccine in Children

PHASE3Completed

15,000 participants

Funding History (20)

8-K

Jan 10, 2002

8-K

Dec 3, 2001

8-K

Sep 4, 2001

8-K

Jul 30, 2001

8-K

Jun 18, 2001

DEF 14A

May 3, 2001

8-K

Feb 2, 2001

8-K

Feb 1, 2001

8-K

Jan 9, 2001

8-K

Jan 4, 2001

Related Companies

Medimmune

acquired